Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Toni K. Choueiri, M.D.

Co-Author

This page shows the publications co-authored by Toni Choueiri and Chris Labaki.
Connection Strength

3.904
  1. Linking a Trio of Molecular Features in Clear-Cell Renal Cell Carcinoma. Cancer Immunol Res. 2022 Mar 01; 10(3):274.
    View in: PubMed
    Score: 0.990
  2. Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic. Cancer Cell. 2021 08 09; 39(8):1042-1044.
    View in: PubMed
    Score: 0.945
  3. Treatment Decisions for Patients with Cancer during the COVID-19 Pandemic. Cancer Discov. 2021 06; 11(6):1330-1335.
    View in: PubMed
    Score: 0.929
  4. From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit. Clin Cancer Res. 2022 Mar 01; 28(5):831-839.
    View in: PubMed
    Score: 0.247
  5. Towards a Better Understanding of Antibody-Drug Conjugates in Urothelial Carcinoma. Eur Urol Oncol. 2022 Jan 29.
    View in: PubMed
    Score: 0.246
  6. Biomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR Trial. Clin Cancer Res. 2022 02 15; 28(4):748-755.
    View in: PubMed
    Score: 0.062
  7. Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study. Open Forum Infect Dis. 2022 Mar; 9(3):ofac037.
    View in: PubMed
    Score: 0.062
  8. Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States. JAMA Netw Open. 2022 01 04; 5(1):e2142046.
    View in: PubMed
    Score: 0.061
  9. Integrative clinical and molecular characterization of translocation renal cell carcinoma. Cell Rep. 2022 01 04; 38(1):110190.
    View in: PubMed
    Score: 0.061
  10. COVID-19 vaccination and breakthrough infections in patients with cancer. Ann Oncol. 2022 03; 33(3):340-346.
    View in: PubMed
    Score: 0.061
  11. HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study. Lancet Oncol. 2022 01; 23(1):172-184.
    View in: PubMed
    Score: 0.061
  12. Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19. JAMA Netw Open. 2021 11 01; 4(11):e2134330.
    View in: PubMed
    Score: 0.060
  13. Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study. Lung Cancer. 2021 10; 160:78-83.
    View in: PubMed
    Score: 0.059
  14. Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors. Int J Cancer. 2021 10 01; 149(7):1455-1462.
    View in: PubMed
    Score: 0.059
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.